You can buy or sell BLPH and other stocks, options, ETFs, and crypto commission-free!
Bellerophon Therapeutics, Inc. Common Stock, also called Bellerophon Therapeutics, is a clinical-stage therapeutics company, which focuses on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Read More The company engages in two programs including INOpulse and BCM. INOpulse is based on proprietary pulsatile nitric oxide delivery device. BCM is based on placebo-controlled clinical trial designed to support CE mark registration in the European Union. Bellerophon Therapeutics was founded in 2009 and is headquartered in Warren, NJ.
Warren, New Jersey
52 Week High
52 Week Low
Expected Nov 6, Pre-Market